Baicalin suppresses the cell cycle progression and proliferation of prostate cancer cells through the CDK6/FOXM1 axis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Baicalin suppresses the cell cycle progression and proliferation of prostate cancer cells through the CDK6/FOXM1 axis
Authors
Keywords
-
Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 469, Issue 1-2, Pages 169-178
Publisher
Springer Science and Business Media LLC
Online
2020-05-09
DOI
10.1007/s11010-020-03739-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biomarker Analyses of Response to Cyclin Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women With Treatment-Naïve Metastatic Breast Cancer
- (2019) Richard S. Finn et al. CLINICAL CANCER RESEARCH
- Hybrid Sequencing of Full-Length cDNA Transcripts of the Medicinal Plant Scutellaria baicalensis
- (2019) Ting Gao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Outcomes of Older Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor–Negative Metastatic Breast Cancer Treated With a CDK4/6 Inhibitor and an Aromatase Inhibitor: An FDA Pooled Analysis
- (2019) Lynn J. Howie et al. JOURNAL OF CLINICAL ONCOLOGY
- 18F-Facbc in Prostate Cancer: A Systematic Review and Meta-Analysis
- (2019) Laudicella et al. Cancers
- Past, Current, and Future of Immunotherapies for Prostate Cancer
- (2019) Adeline N. Boettcher et al. Frontiers in Oncology
- Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial
- (2018) Yuanxing Hang et al. Lipids in Health and Disease
- Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer
- (2018) Huafeng Pan et al. World Journal of Surgical Oncology
- Chinese Medicines in the Treatment of Prostate Cancer: From Formulas to Extracts and Compounds
- (2018) Xueni Wang et al. Nutrients
- Aidi Injection, a Traditional Chinese Medicine Injection, Could Be Used as an Adjuvant Drug to Improve Quality of Life of Cancer Patients Receiving Chemotherapy: A Propensity Score Matching Analysis
- (2018) Gang Xie et al. INTEGRATIVE CANCER THERAPIES
- In vivo effect of quantified flavonoids-enriched extract of Scutellaria baicalensis root on acute lung injury induced by influenza A virus
- (2018) Hai-Juan Zhi et al. PHYTOMEDICINE
- Pharmacokinetic drug evaluation of ribociclib for the treatment of metastatic, hormone-positive breast cancer
- (2017) Giuseppe Curigliano et al. Expert Opinion on Drug Metabolism & Toxicology
- Baicalin in flavocoxid may act against hepatitis B virus via a pro-inflammatory pathway
- (2017) Salvatore Chirumbolo INFLAMMATION RESEARCH
- MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
- (2017) Matthew P. Goetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Regulatory effect of baicalin on the imbalance of Th17/Treg responses in mice with allergic asthma
- (2017) Lu Xu et al. JOURNAL OF ETHNOPHARMACOLOGY
- Baicalin inhibits the metastasis of highly aggressive breast cancer cells by reversing epithelial-to-mesenchymal transition by targeting β-catenin signaling
- (2017) Tao Zhou et al. ONCOLOGY REPORTS
- The Emerging Roles of Forkhead Box (FOX) Proteins in Osteosarcoma
- (2017) Wentao Zhang et al. Journal of Cancer
- Lung-targeting drug delivery system of baicalin-loaded nanoliposomes: development, biodistribution in rabbits, and pharmacodynamics in nude mice bearing orthotopic human lung cancer
- (2016) Yumeng Wei et al. International Journal of Nanomedicine
- Palbociclib and Letrozole in Advanced Breast Cancer
- (2016) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- FOXM1 and androgen receptor co-regulate CDC6 gene transcription and DNA replication in prostate cancer cells
- (2014) Youhong Liu et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Increased FoxM1 expression is a target for metformin in the suppression of EMT in prostate cancer
- (2014) YIRU WANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine
- (2014) Lawrence M. Gelbert et al. INVESTIGATIONAL NEW DRUGS
- Prostate cancer research in China
- (2013) Shan-Cheng Ren et al. ASIAN JOURNAL OF ANDROLOGY
- Anti-asthmatic Effects of Baicalin in a Mouse Model of Allergic Asthma
- (2013) Chunhua Ma et al. PHYTOTHERAPY RESEARCH
- Improvement in Prostate Cancer Survival Over Time
- (2012) Michelle M. Kim et al. CANCER JOURNAL
- A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells
- (2011) Lars Anders et al. CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells
- (2010) Yun Luo et al. JOURNAL OF CONTROLLED RELEASE
- Correlation between anti-fibrotic effect of baicalin and serum cytokines in rat hepatic fibrosis
- (2009) Xiao-Dong Peng et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Mechanisms of bone metastasis in prostate cancer: clinical implications
- (2008) Pavlos Msaouel et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now